Pilot study to establish the treatment of patients with frailty and sarcopenia using the device of promoting neural control of paravertebral muscle
Not Applicable
- Conditions
- ower back pain patients with frailty/sarcopenia, or having muscle weakness in their previous stage
- Registration Number
- JPRN-UMIN000029803
- Lead Sponsor
- Fukuoka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with severe cognitive impairment or mental illness 2. Patients disable to wear the device because of the body size or so 3. Patients enrolled to the other clinical study 4. Patients ineligible to the study based on investigator`s decision 5. Patients who take no proper treatment of lumber spinal canal stenosis, hernia or other diseases which could be a cause for lumbago 6. Patients with vertebral fractures or lower limb fractures developed in 6 months 7. Patients with coxarthrosis 8. Patients with poor general condition such as heart failure 9. Bedridden patients 10. Patients who need treatment of the other disease prior to frailty or sarcopenia caused by lumbago
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain evaluation by VAS, RDQ and SF-MPQ-2,10m walk, Timed Up and Go Test
- Secondary Outcome Measures
Name Time Method Analysis for factors to relate the efficacy of HAL-CB02-assisted training: Gender, age, height, weight, grip strength, lower limb circumference, posture measurement, complicated spinal or spine disease analyzed by CT and muscle cross-sectional area (paravertebral muscle, quadriceps femoris muscle) estimated by CT